Macroplane › Companies › Bayer Aktiengesellschaft

Bayer Aktiengesellschaft (1BAYN.MI)

Sector: Healthcare · Industry: Drug Manufacturers - General · Exchange: Milan

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Headquarters: Leverkusen · Employees: 87757 · Website: https://www.bayer.com

Related Macro Trends

  • Gene Therapy & Precision Medicine

Product categories

  • Bioreactors & Fermenters
  • Cell Culture Media & Reagents
  • Single-Use Systems & Bags
  • Fill-Finish & Sterile Filling
  • Process Chemicals & Gases
  • Cold Chain Logistics & Storage
  • Drug Discovery & Development
  • Specialty Gases & Chemicals
  • mAb & GLP-1 Production Capacity

Competitors of Bayer Aktiengesellschaft

  • ELI LILLY & Co (LLY)
  • NOVO NORDISK A S (NVO)
  • THERMO FISHER SCIENTIFIC INC. (TMO)
  • JOHNSON & JOHNSON (JNJ)
  • AbbVie Inc. (ABBV)
  • Merck & Co., Inc. (MRK)
  • AMGEN INC (AMGN)
  • PFIZER INC (PFE)
  • IQVIA HOLDINGS INC. (IQV)
  • Medpace Holdings, Inc. (MEDP)
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
  • ICON PLC (ICLR)

Frequently asked questions about Bayer Aktiengesellschaft (1BAYN.MI)

What is Bayer Aktiengesellschaft (1BAYN.MI)?

Bayer Aktiengesellschaft (1BAYN.MI) is a publicly traded company in the Healthcare sector (Drug Manufacturers - General), listed on Milan. Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.

Who are Bayer Aktiengesellschaft's main competitors?

Competitors of Bayer Aktiengesellschaft (1BAYN.MI) tracked by Macroplane include ELI LILLY & Co (LLY), NOVO NORDISK A S (NVO), THERMO FISHER SCIENTIFIC INC. (TMO), JOHNSON & JOHNSON (JNJ), AbbVie Inc. (ABBV), Merck & Co., Inc. (MRK), AMGEN INC (AMGN), PFIZER INC (PFE), and 4 more.

Search companies · Macro trends · Industries · Product categories · Baskets